Header Logo

Connection

Richard Grant to Pyridones

This is a "connection" page, showing publications Richard Grant has written about Pyridones.
Connection Strength

0.163
  1. Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States. AIDS Behav. 2018 Nov; 22(11):3540-3549.
    View in: PubMed
    Score: 0.163

© 2024 Kaiser Permanente